Search
News & Events
Funding boost for ORIGINS child and family health researchORIGINS is celebrating a substantial funding increase for its world-class research into child and family health and wellbeing.
News & Events
Big run ends, race for cure continuesOur local legend, brain cancer researcher Jacob Byrne, has crossed the finish line of his final marathon, completing his Big Run for Little Brains - 30 marathons in 30 days, covering 1266km across Perth’s local government areas.
News & Events
Atlas maps a pathway to happy, healthy childhoodThe Child Development Atlas is proving popular even before its official launch - bringing together government services.
Are you pregnant, a parent or a carer of a child aged 0 to 8 years and live in Western Australia? Help us deliver a new early years app.
News & Events
Endgame for deadly heart disease will save hundreds of livesRheumatic heart disease, a deadly yet entirely preventable heart disease taking the lives of Aboriginal and Torres Strait Islander people, is finally on the verge of elimination thanks to new research
News & Events
The Kids Research Institute Australia’s CliniKids wins national disability awardCliniKids has won the Excellence in Allied Health category at the inaugural National Disability Awards, announced in Melbourne tonight.
News & Events
Autism Researcher a Finalist for Western Australian of the YearProfessor Andrew Whitehouse has been named a finalist in the 2023 Western Australian of the Year Awards for his work in transforming clinical support for autistic children in Australia.
News & Events
Researchers at The Kids push back against claims linking paracetamol to autismResearchers at The Kids Research Institute Australia have pushed back against claims by US President Donald Trump linking paracetamol use during pregnancy to autism.
News & Events
Autism researcher named 40 under 40 finalistAndrew Whitehouse has been listed in the WA Business News 40 under 40 awards recognising accomplished and dynamic young leaders in Western Australia.
Research
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second boosterPICOBOO is a randomised, adaptive trial evaluating the immunogenicity, reactogenicity, and safety of COVID-19 booster strategies. We report data for second boosters among individuals 50-<70 years old primed with AZD1222 (50-<70y-AZD1222) until Day 84.